Certara, Inc. (NasdaqGS : CERT) acquired Applied BioMath, LLC (ABM) for $36.6 million on December 12, 2023. Certara acquired ABM for total estimated consideration of $36.594 million. The total estimated consideration includes a portion of contingent consideration that is payable over the next two years in cash, not to exceed $17.55 million. Future payments of contingent consideration are based on achieving certain eligible revenue targets for each of the twelve-month periods ended December 31, 2023 and 2024, respectively.

Certara, Inc. (NasdaqGS : CERT) completed the acquisition of Applied BioMath, LLC on December 12, 2023.